Award

National Cancer Institute PAR-22-090

Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology

Recipient

Yale University

Award Amount

$235,212.00

Ceiling

$235,212.00

Awarded

December 11, 2025

Identifier

PAR-22-090

This award funds a project to develop mechano-transduction technology to improve CAR T-cell therapies for cancer treatment, led by Yale University and the National Cancer Institute.

Description

A research grant opportunity focused on engineering therapeutic cells with force-responsive molecular devices to improve cancer treatment. The project aims to develop a mechano-transduction platform to enhance CAR T-cell therapies. The project is led by Yale University in collaboration with the National Cancer Institute.

View original record